PA
CTSO icon

Parallel Advisors’s Cytosorbents Corp CTSO Stock Holding History

Parallel Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-226
Closed -$1K – 3021
2021
Q4 		$1K Hold
226
– – ﹤0.01% 2853
2021
Q3 		$2K Hold
226
– – ﹤0.01% 2664
2021
Q2 		$2K Hold
226
– – ﹤0.01% 2539
2021
Q1 		$2K Hold
226
– – ﹤0.01% 2454
2020
Q4 		$2K Hold
226
– – ﹤0.01% 2287
2020
Q3 		$2K Hold
226
– – ﹤0.01% 2282
2020
Q2 		$2K Hold
226
– – ﹤0.01% 2176
2020
Q1 		$1K Hold
226
– – ﹤0.01% 2251
2019
Q4 		$1K Buy
+226
New +$986 ﹤0.01% 2299

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Parallel Advisors's CTSO Position: Q1 2022 in Review

Parallel Advisors sold out of Cytosorbents Corp (CTSO) in Q1 2022, closing a stake of 226 shares — an estimated $1K sold.

Parallel Advisors first reported a position in CTSO in Q4 2019 and held it in 9 quarters. The position peaked at $2K in Q3 2021. 88 funds tracked by Wall St. Rank hold CTSO as of Q1 2022.

  • Parallel Advisors reported no remaining Cytosorbents Corp position as of Q1 2022 after selling out during the quarter.
  • Parallel Advisors sold 226 Cytosorbents Corp shares in Q1 2022, an estimated $1K.
  • Parallel Advisors first reported a position in Cytosorbents Corp in Q4 2019 and held it in 9 quarters.
  • Parallel Advisors's Cytosorbents Corp position peaked at $2K in Q3 2021.
  • 88 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2022.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.